Literature DB >> 16936248

High-volume ventilation induces pentraxin 3 expression in multiple acute lung injury models in rats.

Daisuke Okutani1, Bing Han, Marco Mura, Thomas K Waddell, Shaf Keshavjee, Mingyao Liu.   

Abstract

Pentraxin 3 (PTX3) is an acute-phase protein, which can be produced by a variety of tissue cells at the site of infection or inflammation. It plays an important role in innate immunity in the lung and in mediating acute lung injury. The aim of this study was to determine the effect of mechanical ventilation on PTX3 expression in multiple lung injury models. Male Sprague-Dawley rats were challenged with intravenous injection of lipopolysaccharide (LPS) or hemorrhage followed by resuscitation (HS). The animals were then subjected to either relatively higher (12 ml/kg) or lower (6 ml/kg, positive end-expiratory pressure of 5 cmH(2)O) volume ventilation for 4 h. High-volume ventilation significantly enhanced PTX3 expression in the lung, either alone or in combination with LPS or hemorrhage. A significant increase of PTX3 immunohistochemistry staining in the lung was seen in all injury groups. The PTX3 expression was highly correlated with the severity of lung injury determined by blood gas, lung elastance, and wet-to-dry ratio. To determine the effects of HS, LPS, or injurious ventilation (25 ml/kg) alone on PTX3 expression, another group of rats was studied. Injurious ventilation significantly damaged the lung and increased PTX3 expression. A local expression of PTX3 induced by high-volume ventilation, either alone or in combination with other pathological conditions, suggests that it may be an important mediator in ventilator-induced lung injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16936248     DOI: 10.1152/ajplung.00002.2006

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  16 in total

1.  The long way of biomarkers: from bench to bedside.

Authors:  Haibo Zhang; Pierre Damas; Jean-Charles Preiser
Journal:  Intensive Care Med       Date:  2010-01-30       Impact factor: 17.440

2.  Long pentraxin PTX3 deficiency worsens LPS-induced acute lung injury.

Authors:  Bing Han; Jack J Haitsma; Yu Zhang; Xiaohui Bai; Matthew Rubacha; Shaf Keshavjee; Haibo Zhang; Mingyao Liu
Journal:  Intensive Care Med       Date:  2010-11-12       Impact factor: 17.440

3.  Src tyrosine kinase inhibition prevents pulmonary ischemia-reperfusion-induced acute lung injury.

Authors:  Takeshi Oyaizu; Shan-Yu Fung; Atsushi Shiozaki; Zehong Guan; Qiao Zhang; Claudia C dos Santos; Bing Han; Marco Mura; Shaf Keshavjee; Mingyao Liu
Journal:  Intensive Care Med       Date:  2012-02-17       Impact factor: 17.440

4.  Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality.

Authors:  Tommaso Mauri; Giacomo Bellani; Nicolo' Patroniti; Andrea Coppadoro; Giuseppe Peri; Ivan Cuccovillo; Massimo Cugno; Gaetano Iapichino; Luciano Gattinoni; Antonio Pesenti; Alberto Mantovani
Journal:  Intensive Care Med       Date:  2010-01-30       Impact factor: 17.440

5.  Murine mechanical ventilation stimulates alveolar epithelial cell proliferation.

Authors:  Patricia Rose Chess; Randi Potter Benson; William M Maniscalco; Terry W Wright; Michael A O'Reilly; Carl J Johnston
Journal:  Exp Lung Res       Date:  2010-08       Impact factor: 2.459

6.  Biomarkers in acute lung injury: are we making progress?

Authors:  Sushma K Cribbs; Greg S Martin
Journal:  Crit Care Med       Date:  2008-08       Impact factor: 7.598

7.  The long pentraxin PTX3 is crucial for tissue inflammation after intestinal ischemia and reperfusion in mice.

Authors:  Danielle G Souza; Flavio A Amaral; Caio T Fagundes; Fernanda M Coelho; Rosa M E Arantes; Lirlandia P Sousa; Martin M Matzuk; Cecília Garlanda; Alberto Mantovani; Adriana A Dias; Mauro M Teixeira
Journal:  Am J Pathol       Date:  2009-03-12       Impact factor: 4.307

8.  PTX3 as a potential biomarker of acute lung injury: supporting evidence from animal experimentation.

Authors:  Xiaolin He; Bing Han; Xiaohui Bai; Yu Zhang; Marcelo Cypel; Marco Mura; Shaf Keshavjee; Mingyao Liu
Journal:  Intensive Care Med       Date:  2009-11-18       Impact factor: 17.440

9.  Characterization of pentraxin 3 in the horse and its expression in airways.

Authors:  Eve Ramery; Laurence Fievez; Audrey Fraipont; Fabrice Bureau; Pierre Lekeux
Journal:  Vet Res       Date:  2009-10-29       Impact factor: 3.683

10.  Pentraxin 3: an immuno-regulator in the lungs.

Authors:  Jyoti Balhara; Latifa Koussih; Jingbo Zhang; Abdelilah Soussi Gounni
Journal:  Front Immunol       Date:  2013-05-31       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.